Parnell Living Science

About:

Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.

Website: http://www.parnell.com/

Top Investors: SWK Holdings, Armentum Partners, White Oak Healthcare Finance

Description:

Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter. With a world-class, FDA-accredited manufacturing facility in Sydney and operations in the United States, Canada, Middle East and Asia-Pacific, Parnell is committed to continued development of innovative products at the highest standard. Parnell currently markets products for companion, performance and production animals enhanced with proprietary software platforms designed to improve compliance and clinical outcomes. Parnell is poised to bring several new products to market over the next five years addressing up to twelve indications and needs, with a particular focus on the companion animal sector. At Parnell, we believe the combination of our current product portfolio, pipeline of product candidates and business solutions position us to become a leading innovator in animal health. Our value-added approach establishes us as a business partner with our customers, not a commodity provider. That is the Parnell difference.

Total Funding Amount:

$52M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Overland Park, Kansas, United States

Founded Date:

1968-01-01

Contact Email:

info(AT)parnell.com

Founders:

Robert Joseph

Number of Employees:

101-250

Last Funding Date:

2021-02-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai